疼痛管理デバイス - 世界市場の考察、競合情勢、市場予測（2030年）

世界の疼痛管理デバイスの市場規模は、2023年に48億6,000万米ドル、2030年までに76億7,000万米ドルに達し、2024年～2030年の予測期間にCAGRで7.90％の成長が見込まれます。疼痛管理デバイスの需要は主に、慢性疼痛の有病率の上昇、筋骨格系障害の高い有病率、老年人口の急増、疼痛管理デバイスに対する人々の意識の急上昇、革新的な製品を開発するための研究開発投資の向上、医療費の増加などによって促進されています。

疼痛管理デバイスの市場力学

乳がん、肺がん、血液がんなどのさまざまな種類のがんの有病率の上昇が、疼痛管理デバイス市場の主な促進要因となっています。例えば、世界保健機関（WHO）（2022）のデータによると、2020年に世界で乳がん226万例、肺がん221万例、大腸がん193万例、前立腺がん141万例、胃がん109万例が報告されています。神経障害性がん疼痛（NCP）は、がんそのものに起因する神経障害によって引き起こされ、多くのがん患者においてNCP管理は有効ではありません。より優れた疼痛管理デバイスの導入により、がん患者は疼痛から解放される可能性があります。

変形性関節症、関節リウマチなどの整形外科疾患の有病率の上昇も、疼痛管理デバイス市場の重要な促進要因です。世界保健機関（WHO）（2022）によると、筋骨格系疾患は障害の主な原因であり、世界中で約17億1,000万人が骨粗鬆症、変形性関節症、関節リウマチなどの筋骨格系疾患に苦しんでいます。

WHO（2022）によると、2019年に世界中で約5億2,800万人が変形性関節症に苦しんでいます。同じ資料によると、2019年に世界中で1,800万人が関節リウマチに罹患していました。

変形性関節症は、しばしば退行性関節炎または摩耗性関節炎と呼ばれ、関節に影響を及ぼし、最終的には骨の表面の滑らかな軟骨がすり減ります。患者は大きな痛み、浮腫、関節の炎症に直面し、自由に動くことが制限されます。そのため、疼痛管理デバイスが痛みの治療に役立っています。

高齢患者の増加により、医療の提供が変化し、よりよいライフスタイルへの需要が高まると予測されています。近年の調査「Global Population Aging 2020 Report」（国連、2020）によると、老年人口は驚くべきペースで増加する傾向にあります。2020年、世界の65歳以上の高齢者は約7億2,700万人に上りました。2050年までに、このような患者の数は倍増し、15億人に達すると予測されています。腰痛、関節炎、慢性疼痛の症例は年齢とともに増加します。高齢患者は、生活様式を改善するために疼痛管理デバイスを必要としています。したがって、これらすべての要因が疼痛管理デバイス市場の成長を促進すると予測されます。

企業は革新的な製品を開発し発売するため、研究開発に多くの費用を投じています。2019年1月、Boston Scientificは先進の慢性疼痛管理デバイスの発売を発表しましたが、これは知覚麻痺と知覚下療法を組み合わせる機能を持つ、市場では数少ないデバイスの1つであることが確認されました。これにより、同製品に対する認知度が高まり、疼痛管理デバイスの需要が高まることが予測されます。

しかし、過敏反応や術後感染など、疼痛管理デバイスの普及を制限する要因もあり、また疼痛管理デバイスの使用に関するベストプラクティスガイドラインが存在しないことも、疼痛管理デバイス市場の成長を妨げる要因となっています。

疼痛管理デバイスのセグメント分析

デバイスタイプセグメントでは、神経調節・神経刺激デバイスが疼痛管理デバイス市場で最大のシェアを占めると予測されます。この成長は、神経疾患の有病率の増加によるものと考えられます。

例えば、2020年にEpilepsy Centreが発表したデータによると、世界中で約5,000万人の患者がてんかんを患っており、毎年約240万人が新たに診断されています。さらに、世界保健機関（WHO）（2023）のデータによると、世界全体で約5,000万人が認知症を患っており、毎年1,000万人近くが新たに発症しています。このうち約60～70％がアルツハイマー型認知症です。したがって、この負担を軽減するための緊急の対策が必要です。これらの神経刺激デバイスは、慢性疼痛、パーキンソン病、てんかん、運動障害、うつ病の治療に重要な役割を果たしています。これは、神経刺激デバイスの費用対効果、慢性疼痛の緩和における経皮的電気神経刺激（TENS）と脊髄刺激（SCS）デバイスの高い有効性、先進国におけるSCS療法の償還可能性などに起因する可能性があります。

当レポートでは、世界の疼痛管理デバイス市場について調査分析し、市場規模と予測、促進要因と課題、企業と製品のプロファイルなどを提供しています。

目次

第1章 疼痛管理デバイス市場レポートのイントロダクション

第2章 疼痛管理デバイス市場のエグゼクティブサマリー

• 調査範囲
• 市場の概要
• 競合の評価

第3章 規制分析

• 米国
• 欧州
• 日本
• 中国

第4章 疼痛管理デバイス市場の主な要因の分析

• 疼痛管理デバイス市場の促進要因
  • 慢性疼痛の有病率の増加
  • 疼痛管理デバイスに対する人々の意識の急上昇
  • 革新的な製品を開発するための研究開発投資の改善
  • 革新的な製品の発売
  • 医療費の増加
• 疼痛管理デバイス市場の抑制要因と課題
  • これらのデバイスの使用により引き起こされる過敏症反応や術後感染症により、その採用が制限される
  • 製品の高いコスト
• 疼痛管理デバイス市場の機会
  • 新興経済国によってもたらされる未開発の可能性
  • 病院以外の環境における疼痛管理デバイスの需要の増大

第5章 疼痛管理デバイスのポーターのファイブフォース分析

第6章 疼痛管理デバイス市場のレイアウト

• デバイスタイプ別
  • 神経調節・神経刺激デバイス
  • 鎮痛剤注入ポンプ
  • アブレーションデバイス
  • その他
• 用途別
  • 神経障害性疼痛
  • がん疼痛
  • 顔面痛・偏頭痛
  • 筋骨格系疼痛
• 地域別
  • 北米の疼痛管理デバイスの市場規模（2021年～2030年）
  • 欧州の疼痛管理デバイスの市場規模（2021年～2030年）
  • アジア太平洋の疼痛管理デバイスの市場規模（2021年～2030年）
  • その他の地域の疼痛管理デバイスの市場規模（2021年～2030年）

第7章 疼痛管理デバイスの企業と製品のプロファイル

• Abbott Laboratories
• Baxter International Inc.
• Boston Scientific Corporation
• B Braun Melsungen AG
• Nevro Corp.
• Colfax Corporation
• Omron Corporation
• Koninklijke Philips NV
• Smiths Medical
• Medtronic plc.
• Stryker Corporation
• Stimwave LLC
• Kimberly Clark Corporation
• DJO Global LLC.
• Aleva neurotherapeutics SA

第8章 KOLの見解

第9章 プロジェクトのアプローチ

第10章 DelveInsightのサービス内容

第11章 DelveInsightについて

第12章 免責事項とお問い合わせ

List of Tables

• Table 1: Competitive Analysis
• Table 2: Pain Management Devices Market in Global (2021-2030)
• Table 3: Pain Management Devices Market in Global by Type of Devices (2021-2030)
• Table 4: Pain Management Devices Market in Global by Application (2021-2030)
• Table 5: Pain Management Devices Market in Global by Geography (2021-2030)
• Table 6: Pain Management Devices Market in North America (2021-2030)
• Table 7: Pain Management Devices Market in the US (2021-2030)
• Table 8: Pain Management Devices Market in Canada (2021-2030)
• Table 9: Pain Management Devices Market in Mexico (2021-2030)
• Table 10: Pain Management Devices Market in Europe (2021-2030)
• Table 11: Pain Management Devices Market in France (2021-2030)
• Table 12: Pain Management Devices Market in Germany (2021-2030)
• Table 13: Pain Management Devices Market in the United Kingdom (2021-2030)
• Table 14: Pain Management Devices Market in Italy (2021-2030)
• Table 15: Pain Management Devices Market in Spain (2021-2030)
• Table 16: Pain Management Devices Market in Rest of Europe (2021-2030)
• Table 17: Pain Management Devices Market in Asia-Pacific (2021-2030)
• Table 18: Pain Management Devices Market in China (2021-2030)
• Table 19: Pain Management Devices Market in Japan (2021-2030)
• Table 20: Pain Management Devices Market in India (2021-2030)
• Table 21: Pain Management Devices Market in Australia (2021-2030)
• Table 22: Pain Management Devices Market in South Korea (2021-2030)
• Table 23: Pain Management Devices Market in Rest of Asia-Pacific (2021-2030)
• Table 24: Pain Management Devices Market in the Rest of the World (2021-2030)
• Table 25: Pain Management Devices Market in the Middle East (2021-2030)
• Table 26: Pain Management Devices Market in Africa (2021-2030)
• Table 27: Pain Management Devices Market in South America (2021-2030)

List of Figures

• Figure 1: Competitive Analysis
• Figure 2: Pain Management Devices Market in Global (2021-2030)
• Figure 3: Pain Management Devices Market in Global by Type of Devices (2021-2030)
• Figure 4: Pain Management Devices Market in Global by Application (2021-2030)
• Figure 5: Pain Management Devices Market in Global by Geography (2021-2030)
• Figure 6: Pain Management Devices Market in North America (2021-2030)
• Figure 7: Pain Management Devices Market in the US (2021-2030)
• Figure 8: Pain Management Devices Market in Canada (2021-2030)
• Figure 9: Pain Management Devices Market in Mexico (2021-2030)
• Figure 10: Pain Management Devices Market in Europe (2021-2030)
• Figure 11: Pain Management Devices Market in France (2021-2030)
• Figure 12: Pain Management Devices Market in Germany (2021-2030)
• Figure 13: Pain Management Devices Market in the Kingdom (2021-2030)
• Figure 14: Pain Management Devices Market in Italy (2021-2030)
• Figure 15: Pain Management Devices Market in Spain (2021-2030)
• Figure 16: Pain Management Devices Market in Rest of Europe (2021-2030)
• Figure 17: Pain Management Devices Market in Asia-Pacific (2021-2030)
• Figure 18: Pain Management Devices Market in China (2021-2030)
• Figure 19: Pain Management Devices Market in Japan (2021-2030)
• Figure 20: Pain Management Devices Market in India (2021-2030)
• Figure 21: Pain Management Devices Market in Australia (2021-2030)
• Figure 22: Pain Management Devices Market in South Korea (2021-2030)
• Figure 23: Pain Management Devices Market in Rest of Asia Pacific (2021-2030)
• Figure 24: Pain Management Devices Market in the Rest of the World (2021-2030)
• Figure 25: Pain Management Devices Market in the Middle East (2021-2030)
• Figure 26: Pain Management Devices Market in Africa (2021-2030)
• Figure 27: Pain Management Devices Market in South America (2021-2030)
• Figure 28: Market Drivers
• Figure 29: Market Barriers
• Figure 30: Market Opportunities

Pain Management Devices Market By Type Of Devices (Neuromodulation and Neurostimulation Devices, Analgesic Infusion Pumps [Intrathecal Infusion Pumps and External Infusion Pumps], Ablation Devices [Radiofrequency Ablation Devices and Cryoablation Devices], and Others), Application (Neuropathic Pain, Cancer Pain, Facial & Migraine Pain, Musculoskeletal Pain, and Others), and Geography is expected to grow at a steady CAGR Forecast till 2030 owing to rise in prevalence of chronic pain and musculoskeletal disorders and surge in awareness among people toward pain management devices

The global pain management devices market was valued at USD 4.86 billion in 2023, growing at a CAGR of 7.90% during the forecast period from 2024 to 2030, to reach USD 7.67 billion by 2030. The demand for Pain Management Devices is primarily motivated by the rise in the prevalence of chronic pain, the high prevalence of musculoskeletal disorders, the surge in the geriatric population, the surge in awareness among people toward pain management devices, improved R&D investment to develop innovative products, and increasing cost of healthcare expenditure.

Pain Management Devices Market Dynamics:

The rising prevalence of different cancer types such as breast cancer, lung cancer, blood cancer, and others turns out to be an essential factor accelerating the pain management devices market. For instance, according to the data cited by the World Health Organization 2022, worldwide around 2.26 million cases of breast, 2.21 million cases of lung, 1.93 million cases of colon and rectum, 1.41 million cases of prostate, and 1.09 million cases of stomach cancer were reported in 2020. Neuropathic cancer pain (NCP) is caused by nerve damage attributable to cancer per se, and NCP management is ineffective in many cancer patients. With the introduction of better pain management devices, cancer patients may get relief from pain.

The rising prevalence of orthopedic diseases such as osteoarthritis, rheumatoid arthritis, and others is another important driver for the pain management devices market. According to World Health Organization (WHO) 2022, musculoskeletal conditions are the leading contributor to disability and worldwide around 1.71 billion people are suffering from musculoskeletal diseases such as osteoporosis, osteoarthritis, rheumatoid arthritis, and others.

According to WHO 2022, worldwide around 528 million people suffered from osteoarthritis in 2019. As per the same source, worldwide 18 million people had rheumatoid arthritis in 2019.

Osteoarthritis often referred to as degenerative or wear-and-tear arthritis affects the joints and eventually causes the smooth cartilage on the surface of the bones to wear away. Patients face significant pain, edema, and joint inflammation which limits their ability to move freely. Pain management devices are thereby helpful to treat pain.

It is predicted that the rising number of elderly patients would transform healthcare delivery and create a larger demand for a better lifestyle. As per the recent survey, Global Population Aging 2020 Report (United Nations, 2020), the aging population tends to grow at an alarming pace. In 2020, there were around 727 million individuals in the world aged 65 years or older. By 2050, the figure of such patients is expected to double and reach 1.5 billion by 2050. The cases of lower back pain, arthritis, and chronic pain increase with age. Older age patients require pain management devices to improve their living style. Thus, all these factors are projected to drive the growth of the market for pain management devices.

Companies are spending more on research and development for developing and launching innovative products. In January 2019, Boston Scientific announced the launch of an advanced chronic pain management device, which has been identified as one of the very few devices in the market with the ability to combine paresthesia and sub-perception therapy. This is expected to increase awareness about the product and boost the demand for pain management devices.

Certain factors such as hypersensitivity reactions and post-operative infections caused due to the use of these devices limit their adoption the pain management devices and also non-availability of best practice guidelines for using pain management devices poses a minor hurdle for the growth of the pain management devices market.

Pain Management Devices Segment Analysis:

By Type of Devices (Neuromodulation and Neurostimulation Devices, Analgesic Infusion Pumps [Intrathecal Infusion Pumps and External Infusion Pumps], Ablation Devices [Radiofrequency Ablation Devices and Cryoablation Devices], and Others), Application (Neuropathic Pain, Cancer Pain, Facial & Migraine Pain, Musculoskeletal Pain, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World).

In the type of devices segment, neuromodulation, and neurostimulation devices are expected to hold the largest share in the pain management devices market. The growth can be attributed to the increased prevalence of neurological disorders.

For instance, around 50 million patients are living with epilepsy worldwide, and around 2.4 million new cases are diagnosed annually, as per the data published by the Epilepsy Centre in 2020. Furthermore, According to World Health Organisation (2023) data, globally, around 50 million people have dementia, and there are nearly 10 million new cases every year. Around 60-70% of these cases are of Alzheimer's. Urgent measures to reduce this burden are therefore needed. These neurostimulators play a crucial role in treating chronic pain, Parkinson's disease, epilepsy, movement disorders, and depression. This can be due to the cost-effectiveness of neurostimulation devices, the high efficacy of transcutaneous electrical nerve stimulation (TENS) and spinal cord stimulation (SCS) devices in alleviating chronic pain, and the availability of reimbursement for SCS therapy in developed countries

Moreover, the approval of various neurostimulation devices for the treatment of chronic pain is also expected to surge segment growth.

For instance, in September 2020, Nerivio®, a smartphone-controlled electroceutical device developed by Theranica Bioelectronics for the acute treatment of episodic or chronic migraine in adolescents received CE mark approval.

Further, key market players indulge in research and development for the development of neuromodulation and neurostimulation devices for the treatment of chronic pain could also augment the market.

Recently on January 21, 2021, Saluda Medical Pty Limited announced the positive data from multiple studies evaluating the company's Evoke® ECAP-Controlled, Closed-Loop Spinal Cord Stimulation (SCS) System for the treatment of chronic pain.

Hence, all the aforementioned factors will contribute to the segmental growth of the pain management devices market.

North America is expected to dominate the overall Pain Management Devices Market:

North America is expected to dominate the overall pain management devices market during the forecast period. The growing prevalence of chronic pain in the region is anticipated to boost the demand for pain management devices during the forecasted period.

For instance, as per the data published in the year 2021 by the Centers for Disease Control and Prevention (CDC), it has been estimated that there will be around 78.4 million people suffering from doctor-diagnosed arthritis by 2040, and out of that two-thirds will be the women population.

As per the same source, an estimated 34.6 million adults will face arthritis-attributable activity limitations in the US by 2040. Arthritis is linked with pain in joints. There are many drug-free options for patient to consider, such as TENS, such as device TENS therapy by Omron Health.

Additionally, recent product approval and launches by the companies actively manufacturing devices for pain management will also contribute to the market growth.

For instance, in June 2021, NeuraLace announced FDA 510(k) clearance and the US Launch of Axon Therapy® Peripheral Nerve Stimulation System for chronic pain relief.

Moreover, increasing government initiatives, such as the Precision Medicine and Affordable Care Act, along with a well-planned reimbursement scenario in this region is contributing to market growth.

Thus, all the above-mentioned factors will lead to an increase in the United States pain management devices market growth during the forecasting period of 2024-2030.

Pain Management Devices Market Key Players:

Some of the key market players operating in the pain management devices market include Smiths Medical, B. Braun Melsungen AG, Baxter, Boston Scientific Corp., Colfax Corp., Medtronic Plc, Nevro Corp., Abbott, Stryker, Omron Healthcare, Inc., Stimwave LLC, and others.

Recent Developmental Activities in the Pain Management Devices Market:

In July 2022, Nevro Corp. received FDA approval for its Senza® System for the treatment of chronic pain associated with Painful Diabetic Neuropathy (PDN).

In July 2022, Unity HA received Breakthrough Device Designation by FDA for the Pulsante® SPG Microstimulator System for the treatment of acute pain associated with chronic cluster headaches.

In May 2022, SoftWave Tissue Regeneration Technologies patented extracorporeal shock wave device called the OrthGold 100® was cleared by the FDA, for the indications of a temporary increase in local blood circulation, relief of minor aches and pains, and activation of connective tissue.

Key Takes Away from the Pain Management Devices Market Report Study

Market size analysis for current market size (2023), and market forecast for 5 years (2024-2030)

Top key product/services/technology developments, mergers, acquisitions, partnerships, and joint ventures happened for the last 3 years

Key companies dominating the global pain management devices market.

Various opportunities available for the other competitor in the pain management devices market space.

What are the top-performing segments in 2023? How these segments will perform in 2030?

Which are the top-performing regions and countries in the current market scenario?

Which are the regions and countries where companies should have concentrated on opportunities for market growth in the coming future?

Target Audience who can be benefited from This Pain Management Devices Market Report Study

Pain Management Devices providers

Research organizations and consulting companies

Pain Management Devices-related organization, association, forum, and other alliances

Government and corporate offices

Start-up companies, venture capitalists, and private equity firms

Distributors and Traders

Various End-Users who want to know more about the pain management devices market and the latest technological developments in the pain management devices market.

Frequently Asked Questions for the Pain Management Devices Market:

1. What are Pain Management Devices?

Pain management devices are medical devices that are used in management of different types of pain such as neuropathic pain, cancer pain, nociceptive pain, musculoskeletal pain, and others.

2. What is the market for global pain management devices?

The global pain management devices market was valued at USD 4.86 billion in 2023, growing at a CAGR of 7.90% during the forecast period from 2024 to 2030, to reach USD 7.67 billion by 2030.

3. What are the drivers for the pain management devices market?

The major drivers driving the demand for pain management devices are the increase in the prevalence of chronic pain, the high prevalence of musculoskeletal disorders, the surge in the geriatric population, the surge in awareness among people toward pain management devices, and the growing cost of healthcare expenditure.

4. Who are the key players operating in the global pain management devices market?

Some of the key market players operating in the pain management devices market include Smiths Medical, B. Braun Melsungen AG, Baxter, Boston Scientific Corp., Colfax Corp., Medtronic Plc, Nevro Corp., Abbott, Stryker, Omron Healthcare, Inc., Stimwave LLC and others.

5. Which region has the highest share in the pain management devices market?

North America is expected to dominate the overall pain management devices market during the forecast period, 2024 to 2030. this domination is due to the growing demand for advance technologies, the increasing chronic disease in the region, and the high adoption of technological advancements owing to the rise in healthcare expenditure by the US government.

Table of Contents

1. Pain Management Devices Market Report Introduction

2. Pain Management Devices Market Executive Summary

• 2.1. Scope of the Study
• 2.2. Market at Glance
• 2.3. Competitive Assessment

3. Regulatory Analysis

• 3.1. The United States
• 3.2. Europe
• 3.3. Japan
• 3.4. China

4. Pain Management Devices Market Key Factors Analysis

• 4.1. Pain Management Devices Market Drivers
  • 4.1.1. Rise in prevalence of chronic pain
  • 4.1.2. Surge in awareness among people toward pain management devices
  • 4.1.3. Improved R&D investment to develop innovative products
  • 4.1.4. Launch of innovative products
  • 4.1.5. Increasing cost of healthcare
• 4.2. Pain Management Devices Market Restraints and Challenges
  • 4.2.1. Hypersensitivity reactions and post-operative infections caused due to use of these devices limit their adoption
  • 4.2.2. High Cost of product
• 4.3. Pain Management Devices Market Opportunities
  • 4.3.1. Untapped potential offered by developing economies
  • 4.3.2. Growing demand for Pain Management Devices in non-hospital settings

5. Pain Management Devices Porter's Five Forces Analysis

• 5.1. Bargaining Power of Suppliers
• 5.2. Bargaining Power of Consumers
• 5.3. Threat of New Entrants
• 5.4. Threat of Substitutes
• 5.5. Competitive Rivalry

6. Pain Management Devices Market Layout

• 6.1. By Type of Devices
  • 6.1.1. Neuromodulation & Neurostimulation Devices
  • 6.1.2. Analgesic Infusion Pumps
    • 6.1.2.1. Intrathecal Infusion Pumps
    • 6.1.2.2. External Infusion Pumps
  • 6.1.3. Ablation Devices
    • 6.1.3.1. Radiofrequency Ablation Devices
    • 6.1.3.2. Cryoablation Devices
  • 6.1.4. Others
• 6.2. By Application
  • 6.2.1. Neuropathic Pain
  • 6.2.2. Cancer Pain
  • 6.2.3. Facial & Migraine Pain
  • 6.2.4. Musculoskeletal Pain
  • 6.2.5. Others
• 6.3. By Geography
  • 6.3.1. North America Pain Management Devices Market Size in USD million (2021-2030)
    • 6.3.1.1. United States Pain Management Devices Market Size in USD million (2021-2030)
    • 6.3.1.2. Canada Pain Management Devices Market Size in USD million (2021-2030)
    • 6.3.1.3. Mexico Pain Management Devices Market Size in USD million (2021-2030)
  • 6.3.2. Europe Pain Management Devices Market Size in USD million (2021-2030)
    • 6.3.2.1. France Pain Management Devices Market Size in USD million (2021-2030)
    • 6.3.2.2. Germany Pain Management Devices Market Size in USD million (2021-2030)
    • 6.3.2.3. United Kingdom Pain Management Devices Market Size in USD million (2021-2030)
    • 6.3.2.4. Italy Pain Management Devices Market Size in USD million (2021-2030)
    • 6.3.2.5. Spain Pain Management Devices Market Size in USD million (2021-2030)
    • 6.3.2.6. Rest of Europe Pain Management Devices Market Size in USD million (2021-2030)
  • 6.3.3. Asia-Pacific Pain Management Devices Market Size in USD million (2021-2030)
    • 6.3.3.1. China Pain Management Devices Market Size in USD million (2021-2030)
    • 6.3.3.2. Japan Pain Management Devices Market Size in USD million (2021-2030)
    • 6.3.3.3. India Pain Management Devices Market Size in USD million (2021-2030)
    • 6.3.3.4. Australia Pain Management Devices Market Size in USD million (2021-2030)
    • 6.3.3.5. South Korea Pain Management Devices Market Size in USD million (2021-2030)
    • 6.3.3.6. Rest of Asia Pacific Pain Management Devices Market Size in USD million (2021-2030)
  • 6.3.4. Rest of the World (RoW) Pain Management Devices Market Size in USD million (2021-2030)
    • 6.3.4.1. Middle East Pain Management Devices Market Size in USD million (2021-2030)
    • 6.3.4.2. Africa Pain Management Devices Market Size in USD million (2021-2030)
    • 6.3.4.3. South America Pain Management Devices Market Size in USD million (2021-2030)

7. Pain Management Devices Company and Product Profiles

• 7.1. Abbott Laboratories
  • 7.1.1. Company Overview
  • 7.1.2. Company Snapshot
  • 7.1.3. Financial Overview
  • 7.1.4. Product Listing
  • 7.1.5. Entropy
• 7.2. Baxter International Inc.
  • 7.2.1. Company Overview
  • 7.2.2. Company Snapshot
  • 7.2.3. Financial Overview
  • 7.2.4. Product Listing
  • 7.2.5. Entropy
• 7.3. Boston Scientific Corporation
  • 7.3.1. Company Overview
  • 7.3.2. Company Snapshot
  • 7.3.3. Financial Overview
  • 7.3.4. Product Listing
  • 7.3.5. Entropy
• 7.4. B Braun Melsungen AG
  • 7.4.1. Company Overview
  • 7.4.2. Company Snapshot
  • 7.4.3. Financial Overview
  • 7.4.4. Product Listing
  • 7.4.5. Entropy
• 7.5. Nevro Corp.
  • 7.5.1. Company Overview
  • 7.5.2. Company Snapshot
  • 7.5.3. Financial Overview
  • 7.5.4. Product Listing
  • 7.5.5. Entropy
• 7.6. Colfax Corporation
  • 7.6.1. Company Overview
  • 7.6.2. Company Snapshot
  • 7.6.3. Financial Overview
  • 7.6.4. Product Listing
  • 7.6.5. Entropy
• 7.7. Omron Corporation
  • 7.7.1. Company Overview
  • 7.7.2. Company Snapshot
  • 7.7.3. Financial Overview
  • 7.7.4. Product Listing
  • 7.7.5. Entropy
• 7.8. Koninklijke Philips NV
  • 7.8.1. Company Overview
  • 7.8.2. Company Snapshot
  • 7.8.3. Financial Overview
  • 7.8.4. Product Listing
  • 7.8.5. Entropy
• 7.9. Smiths Medical
  • 7.9.1. Company Overview
  • 7.9.2. Company Snapshot
  • 7.9.3. Financial Overview
  • 7.9.4. Product Listing
  • 7.9.5. Entropy
• 7.10. Medtronic plc.
  • 7.10.1. Company Overview
  • 7.10.2. Company Snapshot
  • 7.10.3. Financial Overview
  • 7.10.4. Product Listing
  • 7.10.5. Entropy
• 7.11. Stryker Corporation
  • 7.11.1. Company Overview
  • 7.11.2. Company Snapshot
  • 7.11.3. Financial Overview
  • 7.11.4. Product Listing
  • 7.11.5. Entropy
• 7.12. Stimwave LLC
  • 7.12.1. Company Overview
  • 7.12.2. Company Snapshot
  • 7.12.3. Financial Overview
  • 7.12.4. Product Listing
  • 7.12.5. Entropy
• 7.13. Kimberly Clark Corporation
  • 7.13.1. Company Overview
  • 7.13.2. Company Snapshot
  • 7.13.3. Financial Overview
  • 7.13.4. Product Listing
  • 7.13.5. Entropy
• 7.14. DJO Global LLC.
  • 7.14.1. Company Overview
  • 7.14.2. Company Snapshot
  • 7.14.3. Financial Overview
  • 7.14.4. Product Listing
  • 7.14.5. Entropy
• 7.15. Aleva neurotherapeutics SA
  • 7.15.1. Company Overview
  • 7.15.2. Company Snapshot
  • 7.15.3. Financial Overview
  • 7.15.4. Product Listing
  • 7.15.5. Entropy

8. KOL Views

9. Project Approach

10. DelveInsight Capabilities

11. About DelveInsight

12. Disclaimer & Contact Us